New from Dr Musah in STAR protocols
Protocol for the development and transcriptomic analysis of multiple human kidney disease models
https://t.co/lqJzHnoA5u
New from #NephFellow Dr DeMis and colleagues in JACC Case Reports
Right Atrial Cardiac Fibroma Mimicking Eustachian Valve Endocarditis in Neutropenic Sepsis: A Diagnostic Challenge
https://t.co/AFKOQOik4O
Sunday Read💫: A novel axis that can fine-tune the immune response to glomerular and tubule cell damage: https://t.co/wrothZ1uS4
Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney@Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating
autoimmune nephritis.
The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top).
#AKI #Nephrology #kidney #macrophage
Congrats to #NephFaculty Dr Sparks who will give the Burton D. Rose, MD, Endowed Lectureship at ASN Kidney Week 2026 in Denver CO, Oct 22nd
“Formulating a Dialysis Access Curriculum: Bridging the Gap in Education and Training”
https://t.co/RgMNOnEAi0
Presenting a novel axis that can fine-tune the immune response to glomerular and tubule cell damage:
Jamie R. Privratsky @JamiePrivratsky & team @DukeKidney@Duke_Anesthesia identify a novel myeloid cell-endothelial cell immunoregulatory axis, supporting a model whereby myeloid IL-1R1 activity constrains ER stress–mediated EBI3/IL27 secretion, thereby attenuating type I IFN expression in kidney endothelial cells and ameliorating
autoimmune nephritis.
The figure shows anti-IFNAR1 therapy abrogates kidney injury after NTS nephritis in mice lacking IL-1R1 specifically in myeloid cells (bottom); littermate controls (top).
#AKI #Nephrology #kidney #macrophage
New from #NephFaculty Dr Ortiz-Melo and Dr Coffman in JCI Insight
Proximal tubule ACE2 mediates early responses to hypertension by regulating intrarenal RAS and sodium homeostasis
https://t.co/bfsE3v1RU9
New form #NephFaculty Dr Rasheeda Hall and colleagues in Nature Reviews Nephrology
Recommendations for the management of frailty in chronic kidney disease: a consensus report
https://t.co/kVGQy2EK14
#FellowLife
1st year: Dr. Josh Daum
Residency (chief resident): Mayo Clinic – Rochester, MN
Med School: Mayo Clinic Alix School of Medicine – Phoenix, AZ
https://t.co/vNXZW5yLC5
Congrats to #NephFaculty Dr Matthew Sinclair on his K23 NIH NIDDK grant titled #NephForward
“Promoting Evidence-Based Chronic Kidney Disease Care among Hispanics/Latinos with Type 2 Diabetes”
Welcome Sydney Hege, PharmDClinical Pharmacist Practitionerto Duke Nephrology
She will see patients in our ambulatory clinics focusing on Kidney GDMT and CKM Syndrome
#NephFaculty Dr Anna Strasma featured in the Duke Climate Commitment Impact Report 2026
Early Warning Systems Within a Warming World: Extreme Heat and Human Health
https://t.co/PeIYrqCiET
#FellowLife
2nd year (chief fellow): Dr. Samiddhi Weerasiri
Residency: Mayo Clinic – Rochester
Med School: Virginia Commonwealth University
https://t.co/2rT8GQWAcX
#FellowLife
1st year: Dr. Chelsea Smith
Residency: University of Kansas
Med School: University of Arkansas for Medical Sciences
https://t.co/RjkG1YkpAf